Atossa Genetics Inc (ATOS)

Currency in MXN
16.50
+0.50(+3.12%)
Closed·
ATOS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.5016.50
52 wk Range
13.0031.51
Key Statistics
Prev. Close
-
Open
16.5
Day's Range
16.5-16.5
52 wk Range
13-31.51
Volume
19
Average Volume (3m)
186
1-Year Change
-36.54%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATOS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Atossa Genetics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Atossa Genetics Inc Company Profile

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company’s lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Compare ATOS to Peers and Sector

Metrics to compare
ATOS
Peers
Sector
Relationship
P/E Ratio
0.0x−2.0x−0.5x
PEG Ratio
0.00−0.040.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
0.0x87.7x3.2x
Upside (Analyst Target)
0.0%216.6%41.9%
Fair Value Upside
Unlock18.7%4.3%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ATOS Income Statement

People Also Watch

12.850
BBVA
+1.78%
126.05
CRWV
-2.87%
29.42
CNC
+5.49%
88.53
QRVO
+0.83%
58.920
ASTS
+3.21%

FAQ

What Stock Exchange Does Atossa Genetics Inc Trade On?

Atossa Genetics Inc is listed and trades on the BIVA stock exchange.

What Is the Stock Symbol for Atossa Genetics Inc?

The stock symbol for Atossa Genetics Inc is "ATOS."

What Is the Atossa Genetics Inc Market Cap?

As of today, Atossa Genetics Inc market cap is 2.12B.

What Is Atossa Genetics Inc's Earnings Per Share (TTM)?

The Atossa Genetics Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is ATOS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Atossa Genetics Inc Stock Split?

Atossa Genetics Inc has split 0 times.

What is the current trading status of Atossa Genetics Inc (ATOS)?

As of 24 Jul 2025, Atossa Genetics Inc (ATOS) is trading at a price of 16.50, with a previous close of 0.00. The stock has fluctuated within a day range of 16.50 to 16.50, while its 52-week range spans from 13.00 to 31.51.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.